Ligand Pharmaceuticals is a specialty pharmaceutical company that discovers, develops and markets small molecule drugs to address critical, unmet medical needs. The company markets four oncology and dermatology products in the United States: ONTAK, Targretin capsules, Targretin gel and Panretin gel. Ligand's fifth and newest product AVINZA, is a treatment for chronic, moderate-to-severe pain. Its network of major pharmaceutical partners is developing products for hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand Pharmaceuticals is located in San Diego.
Partial Data by Infogroup (c) 2024. All rights reserved.